Ilaris 150 MG/ML vialml
Ended Awarded
- Contract number
- SPE2DB25FX2AZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,655
Award facts
- Contract value 100% obligated
- $25,655.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,655.02 to DMS Pharmaceutical Group Inc. for ILARIS 150 mg/ml vials, a specialty pharmaceutical product. The award, issued on July 31, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026, which authorizes the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical items supporting military healthcare facilities worldwide.
DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, that specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to federal agencies and military healthcare systems. The contract includes no set-aside designation, allowing the vendor to compete effectively in federal procurement markets. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain through its SPE2DB program contract with DLA, with a proven track record of delivering diverse pharmaceutical products ranging from specialty medications and oncology treatments to vaccines and medical devices to Department of Defense healthcare sites nationwide.
Quick answers
Who was awarded contract SPE2DB25FX2AZ?
SPE2DB25FX2AZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FX2AZ worth?
The government has obligated $25,655 on SPE2DB25FX2AZ.
Is contract SPE2DB25FX2AZ an order under another contract?
Yes. SPE2DB25FX2AZ is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2AZ competed?
The extent of competition for SPE2DB25FX2AZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award